Publication:
GENYOi005-A: An induced pluripotent stem cells (iPSCs) line generated from a patient with Familial Platelet Disorder with associated Myeloid Malignancy (FPDMM) carrying a p.Thr196Ala variant.

dc.contributor.authorLamolda, Mar
dc.contributor.authorMontes, Rosa
dc.contributor.authorSimón, Iris
dc.contributor.authorPerales, Sonia
dc.contributor.authorMartínez-Navajas, Gonzalo
dc.contributor.authorLopez-Onieva, Lourdes
dc.contributor.authorRíos-Pelegrina, Rosa
dc.contributor.authorDel Moral, Raimundo García
dc.contributor.authorGriñan-Lison, Carmen
dc.contributor.authorMarchal, Juan A
dc.contributor.authorLozano, Maria L
dc.contributor.authorRamos-Mejia, Veronica
dc.contributor.authorRivera, Jose
dc.contributor.authorBastida, Jose M
dc.contributor.authorReal, Pedro J
dc.date.accessioned2023-02-08T14:37:14Z
dc.date.available2023-02-08T14:37:14Z
dc.date.issued2019-10-15
dc.description.abstractFamilial Platelet Disorder with associated Myeloid Malignancy (FPDMM) is a rare platelet disorder caused by mutations in RUNX1. We generated an iPSC line (GENYOi005-A) from a FPDMM patient with a non-previously reported variant p.Thr196Ala. Non-integrative Sendai viruses expressing the Yamanaka reprogramming factors were used to reprogram peripheral blood mononuclear cells from this FPDMM patient. Characterization of GENYOi005-A included genetic analysis of RUNX1 locus, Short Tandem Repeats profiling, alkaline phosphatase enzymatic activity, expression of pluripotency-associated factors and differentiation studies in vitro and in vivo. This iPSC line will provide a powerful tool to study developmental alterations of FPDMM patients.
dc.identifier.doi10.1016/j.scr.2019.101603
dc.identifier.essn1876-7753
dc.identifier.pmid31698193
dc.identifier.unpaywallURLhttps://doi.org/10.1016/j.scr.2019.101603
dc.identifier.urihttp://hdl.handle.net/10668/14652
dc.journal.titleStem cell research
dc.journal.titleabbreviationStem Cell Res
dc.language.isoen
dc.organizationIBS
dc.page.number101603
dc.pubmedtypeJournal Article
dc.pubmedtypeResearch Support, Non-U.S. Gov't
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject.meshBlood Coagulation Disorders, Inherited
dc.subject.meshBlood Platelet Disorders
dc.subject.meshCell Differentiation
dc.subject.meshCells, Cultured
dc.subject.meshCellular Reprogramming
dc.subject.meshCore Binding Factor Alpha 2 Subunit
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshInduced Pluripotent Stem Cells
dc.subject.meshLeukemia, Myeloid, Acute
dc.subject.meshLeukocytes, Mononuclear
dc.subject.meshMiddle Aged
dc.subject.meshMutation
dc.titleGENYOi005-A: An induced pluripotent stem cells (iPSCs) line generated from a patient with Familial Platelet Disorder with associated Myeloid Malignancy (FPDMM) carrying a p.Thr196Ala variant.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number41
dspace.entity.typePublication

Files